Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer

Sayed Reshad Ghafouri; Suvarna Guvvala; Catherine Jones; Alexander Philipovskiy

doi:10.1136/jim-2021-002298

Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer

Sayed Reshad Ghafouri, Suvarna Guvvala, Catherine Jones, Alexander Philipovskiy

DOI: 10.1136/jim-2021-002298 Published 15 August 2022

Sayed Reshad Ghafouri

1 Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Sayed Reshad Ghafouri

Suvarna Guvvala

1 Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Jones

2 Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Philipovskiy

3 Texas Tech University Health Sciences Medical Center, Lubbock, Texas, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alexander Philipovskiy

Article
Figures & Data
eLetters
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

PURCHASE SHORT TERM ACCESS

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext

Vol 70 Issue 6 Table of Contents

Journal of Investigative Medicine: 70 (6)

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
AFMR Highlights
Front Matter (PDF)

Thank you for your interest in spreading the word on JIM.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer

Message Subject (Your Name) has sent you a message from JIM

Message Body (Your Name) thought you would like to see the JIM web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.